188 related articles for article (PubMed ID: 34021925)
1. Systemic sarcoidosis reactions as a result of tumour necrosis factor-alpha treatment for patients with psoriasis.
Bewley AP; Maleki S
Clin Exp Dermatol; 2021 Dec; 46(8):1548-1550. PubMed ID: 34021925
[TBL] [Abstract][Full Text] [Related]
2. Pulmonary and Lymph Node Sarcoidosis Associated With Anti-Tumor Necrosis Factor Therapy in a Patient With Psoriasis: A New Case of This Paradoxical Phenomenon.
Padilla-España L; Habicheyn-Hiar S; de Troya M
Actas Dermosifiliogr; 2015 Nov; 106(9):760-2. PubMed ID: 26076874
[No Abstract] [Full Text] [Related]
3. Management with secukinumab of tumour necrosis factor inhibitor-induced pulmonary sarcoidosis-like reaction in a patient with psoriasis.
Eichhoff G
Clin Exp Dermatol; 2020 Jun; 45(4):455-456. PubMed ID: 31541476
[No Abstract] [Full Text] [Related]
4. Adalimumab-induced pulmonary sarcoidosis not progressing upon treatment with etanercept.
Jung JH; Kim JH; Song GG
Z Rheumatol; 2017 May; 76(4):372-374. PubMed ID: 28124746
[TBL] [Abstract][Full Text] [Related]
5. Sarcoidosis-Like Lesions: Another Paradoxical Reaction to Anti-TNF Therapy?
Decock A; Van Assche G; Vermeire S; Wuyts W; Ferrante M
J Crohns Colitis; 2017 Mar; 11(3):378-383. PubMed ID: 27591675
[TBL] [Abstract][Full Text] [Related]
6. Paradoxical Hidradenitis Suppurativa in Patients Receiving TNF-α Inhibitors: Case Series, Systematic Review, and Case Meta-Analysis.
Salvador-Rodriguez L; Montero-Vílchez T; Arias-Santiago S; Molina-Leyva A
Dermatology; 2020; 236(4):307-313. PubMed ID: 32135533
[TBL] [Abstract][Full Text] [Related]
7. Histopathologic study of paradoxical psoriasis induced by antitumor necrosis factor alpha therapy: Is it true psoriasis?
Navarro R; Villar-Zarra K; Juarez Á; Daudén E
J Cutan Pathol; 2021 Jun; 48(6):813-816. PubMed ID: 33205481
[No Abstract] [Full Text] [Related]
8. New onset sarcoid-like granulomatosis developing during anti-TNF therapy: an under-recognised complication.
Tong D; Manolios N; Howe G; Spencer D
Intern Med J; 2012 Jan; 42(1):89-94. PubMed ID: 22389903
[TBL] [Abstract][Full Text] [Related]
9. [Sarcoid-like granulomatosis in patients treated with anti-TNFα].
Petrovici A; Kaiser MJ; Louis R; Nguyen Dang D
Rev Med Liege; 2016 Mar; 71(3):124-8. PubMed ID: 27311243
[TBL] [Abstract][Full Text] [Related]
10. Tumor necrosis factor-alpha antagonist-induced sarcoidosis.
Clementine RR; Lyman J; Zakem J; Mallepalli J; Lindsey S; Quinet R
J Clin Rheumatol; 2010 Sep; 16(6):274-9. PubMed ID: 20808167
[TBL] [Abstract][Full Text] [Related]
11. Pulmonary sarcoidosis and latent tuberculosis in a patient with psoriasis treated with adalimumab.
Korta DZ; Ochieng P; Fishman D; Katz SE
Dermatol Online J; 2015 Jan; 21(1):. PubMed ID: 25612132
[TBL] [Abstract][Full Text] [Related]
12. First fatal case of systemic suppurative/necrotizing granulomatous disease following etanercept therapy for psoriasis.
Turashvili G; Farmer P
J Dermatolog Treat; 2015 Apr; 26(2):124-7. PubMed ID: 24646144
[TBL] [Abstract][Full Text] [Related]
13. Induction of Autoantibodies and Autoimmune Diseases in Patients with Psoriasis Receiving Tumor Necrosis Factor Inhibitors.
Oter-López B; Llamas-Velasco M; Sánchez-Pérez J; Dauden E
Actas Dermosifiliogr; 2017 Jun; 108(5):445-456. PubMed ID: 28267955
[TBL] [Abstract][Full Text] [Related]
14. Long-term safety and efficacy of anti-tumor necrosis factor-alpha biosimilar agents in the treatment of psoriasis: a single center study.
Ricceri F; Rosi E; Di Cesare A; Scandagli I; Fastame MT; Prignano F
J Dermatolog Treat; 2022 Jun; 33(4):1983-1985. PubMed ID: 33929274
[TBL] [Abstract][Full Text] [Related]
15. Adalimumab Induced Subcutaneous Nodular Sarcoidosis; A Rare Side Effect of Tumor Necrosis Factor-α Inhibitor.
Au S; Mirsaeidi M; Aronson IK; Sweiss NJ
Sarcoidosis Vasc Diffuse Lung Dis; 2014 Oct; 31(3):249-51. PubMed ID: 25363227
[TBL] [Abstract][Full Text] [Related]
16. [Pulmonary and renal involvement in a TNFα antagonist drug-induced sarcoidosis].
Olivier A; Gilson B; Lafontaine S; Pautot JX; Bindi P
Rev Med Interne; 2012 May; 33(5):e25-7. PubMed ID: 21592629
[TBL] [Abstract][Full Text] [Related]
17. Development of cutaneous sarcoidosis during treatment with tumour necrosis alpha factor antagonists.
Lamrock E; Brown P
Australas J Dermatol; 2012 Nov; 53(4):e87-90. PubMed ID: 23157794
[TBL] [Abstract][Full Text] [Related]
18. Development of sarcoidosis during adalimumab therapy for chronic plaque psoriasis.
Marcella S; Welsh B; Foley P
Australas J Dermatol; 2011 Aug; 52(3):e8-11. PubMed ID: 21834808
[TBL] [Abstract][Full Text] [Related]
19. Development of exclusively cutaneous sarcoidosis in patient with rheumatoid arthritis during treatment with etanercept.
Vieira MA; Saraiva MI; Silva LK; Fraga RC; Kakizaki P; Valente NY
Rev Assoc Med Bras (1992); 2016 Nov; 62(8):718-720. PubMed ID: 27992009
[TBL] [Abstract][Full Text] [Related]
20. Sarcoidosis-like reaction secondary to adalimumab treatment in a patient with axial spondyloarthritis.
Gonçalves Pimenta DA; Meira L; Rolo R; Ferreira L
Monaldi Arch Chest Dis; 2022 Jul; 93(1):. PubMed ID: 35791620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
